Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
Recruiting
Observational Study
Mitral Regurgitation
Mitral Valve Prolapse
Ventricular Tachycardia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 90 (estimated)
- Sponsor
- Karolinska Institutet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study objectives:
* To assess the impact of mitral valve surgery for mitral regurgitation on ventricular arrhythmic burden and surrogate markers of fibrosis in patients with arrhytmogenic mitral valve prolapse (MVP) from baseline to 6 months after surgery
* To characterize the molecular landscape of arrhytmogenic MVP
Study design:
-Prospective explorative observational study
Study population:
…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Age 18 and over
* Patients with and without (controls) arrhythmogenic MVP in need of mitral valve surgery for primary mitral regurgitation according to current standard of care
Exclusion criteria
* Secondary mitral regurgitation
* Primary mitral regurgitation not due to degen…
Contacts
No contact information available.